Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

508 public trials 143 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Completed

Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

NCT02208037

Conditions
Acute Leukemia, Anemia, Anemia, Refractory, +35 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Hospital and Clinics Stanford, California, United States
  • University of Florida College of Medicine (Shands) Gainesville, Florida, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
View all 30 locations
View Trial Details
Completed

Study Evaluating CMC-544 In B-Cell Non-Hodgkin's Lymphoma

NCT00073749

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • UAB CCC Clinical Studies Unit Birmingham, Alabama, United States
  • University of Alabama at Birmingham Kirklin Clinic Birmingham, Alabama, United States
  • UAB Russell Ambulatory Pharmacy Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
View all 22 locations
View Trial Details
Completed

A Study of Obinutuzumab [RO5072759 (GA101)] in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma (GATHER)

NCT01414855

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • cCare Encinitas, California, United States
  • University of Colorado Cancer Center Department of Hematology Aurora, Colorado, United States
  • Rocky Mountain Cancer Ctr - Denver (Williams) Denver, Colorado, United States
View all 38 locations
View Trial Details
Completed

Ipilimumab and Rituximab in Treating Patients With Relapsed or Refractory B-cell Lymphoma

NCT01729806

Conditions
CD20 Positive, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
View Trial Details
Completed

Study Evaluating Inotuzumab Ozogamicin [CMC-544] Administered In Combination With Rituximab In Subjects With Non-Hodgkin's Lymphoma (NHL)

NCT00299494

Conditions
B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • University of Alabama at Birmingham- Birmingham, Alabama, United States
  • IDS Pharmacy Birmingham, Alabama, United States
  • University of Alabama at Birmingham- Birmingham, Alabama, United States
  • California Cancer Care, Inc. Greenbrae, California, United States
View all 38 locations
View Trial Details

Related conditions